Martin Short has spent 50 years in the spotlight, but "game show host" was never among his many accolades until now, when he serves as ringleader tonight, July 23, for ABC's "Match Game" revival.

Biogen has discontinued all gene therapy programs using adeno-associated virus (AAV) capsids, instead shifting resources to modalities that have the highest likelihood of achieving better treatment ...

Gene Mazur, 77, of Manchester, CT, died unexpectedly on September 23, 2025. Gene was born in Buffalo, NY on April 5, 1948, to Stanley and Helen Mazur. He was drafted during the Vietnam War, and ...

An experimental gene therapy has slowed the progression of Huntington’s disease by 75 percent, according to results reported by the biotechnology company uniQure this week. Huntington’s is an ...

Scientists report the first therapy to slow the deadly brain disease. A one-time gene therapy treatment has shown remarkable success in slowing the progression of Huntington's disease in a preliminary ...

Adam Feuerstein is a senior writer and biotech columnist, reporting on the crossroads of drug development, business, Wall Street, and biotechnology. He is also a co-host of the weekly biotech podcast ...

Gene Sauerwine, Jr., 45 of Wilkes-Barre, passed away at home after a lengthy illness on Sunday, September 21, 2025. Gene is already deeply missed by his parents Eugene and Cathy (Williamson) Sauerwine ...

An experimental gene therapy has become the first treatment to successfully slow the progression of Huntington’s disease. While the findings are still preliminary, the approach could be a major ...

An experimental gene therapy was found to slow the progression of Huntington’s disease in a “pivotal” Phase 1/2 study, according to drugmaker uniQure, marking a major step toward a potential first ...

Sept 22 (Reuters) - Life sciences company Element Biosciences sued Illumina (ILMN.O), opens new tab on Monday in separate cases in federal courts in California and ...

Gene therapies for rare diseases are frequently developed then discarded by drug companies because they can’t afford to produce the treatment for more patients. Gene therapies for rare diseases are ...